" class="no-js "lang="en-US"> SCIENION - Medtech Alert
Saturday, April 19, 2025
SCIENION | Pharmtech Focus

SCIENION

About SCIENION

SCIENION

SCIENION is the leading manufacturer of robust, high performance dispensing automation for applications requiring precise deposition of biological content in ultra-low volumes. Our non-contact technology is ideally suited for loading of oligonucleotides, proteins, antibodies, and glycans onto diagnostics devices. Enabled by very flexible software, our systems are used from early R&D activities, all the way through to manufacturing millions of devices per year. Easy scale up is facilitated by the fact that the same core technologies are engineered into all of our systems.

In our portoflio, SCIENION also offers a line of readers, optimized for quantitative array reading on both slides and microtiter plates. Available in colorimetric and fluorescence, these readers are designed with the goal to surpass all pre-existing commercial readers and become the industry standard for assay kits in central labs.

Additionally, through our subsidiary Cellenion, we have developed new technology enabling the dispensing of single-cells. The ability to manipulate single-cells has long been a challenge for the scientific community due to their micrometric size and delicate nature. We have developed and patented a breakthrough technology called cellenONE, allowing high throughput isolation and dispensing of single cells onto a wide range of substrates.

We also offer our assay development and contract manufacturing services, offering a spectrum of full solutions involving the full manufacturing process including wafer prep, surface functionalization, dicing, content spotting, QC, cartridge assembly, functional QC, and packaging.

Related Story

SCIENION Partners with Institute for Prevention and Occupational Medicine (IPA) to Develop UROfast, a Rapid Bladder Cancer Diagnostics Platform

January 19 2022

Today SCIENION, a BICO company and leading developer of miniaturized multiplex diagnostic tests, announced a […]

BICO and Nanochon Announce Commercial Agreement to Develop 3D Printed Joint Restoration Implant

December 9 2021

Today BICO, the world’s leading bio convergence company, announced partnership with Nanochon, a startup developing regenerative joint replacements. Under […]

SCIENION & Cellenion Launch spheroONE ®, a Large-Particle Sorter and Dispenser to Advance Drug Testing on Complex In-Vitro 3D Models

October 27 2021

Today, SCIENION & Cellenion, BICO companies, announced the launch of spheroONE, an innovative single large-particle sorter and dispenser which will […]